#RheumPearl: Dr. J Stone shares useful #ophthalmology terms that #rheums should know. Note that IOI may not be idiopathic (do the workup- it might be #sarcoid myositis). Does @DGlaucomflecken have anything to add? #ACR22 @rheumnow https://t.co/bxWm7MlePj

Michailidou et al. Predictive models VTE in GCA. Predictors Age, inpatient status at the time of diagnosis of GCA, numberof admissions before diagnosis of GCA, Charlson comorbidity index @rheumnow #ACR22 Abstr#0458 https://t.co/TVZ53sERrS https://t.co/JzUuEZThY0

• Predictive Models for Thromboembolic Events in Giant Cell Arteritis: A US Veter…

BIOBADASAR study of cancer risk in RA patients with prev cancer treated with b/tsDMARD. No increased risk, but yet again abatacept numbers are making me slightly nervous! @rheumnow #ACR22 Abstr#0267 https://t.co/H8gYm9STT3 https://t.co/sEIS6Ljwao

• Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheuma…

Rheumatology Secrets & Pearl Lecture with Dr. John Stone: - Patient presenting with fever, headache, neck pain, and CPPD of multiple joints. - Consider Crowned Dens Syndrome. CT Neck showing calcification around Odontoid Process @RheumNow #ACR22 https://t.co/Md1bqzPyr5

Henningson et al. IV methylpred in GCA. No better visual acuity, higher cumulative GC at 3 months, higher diabetes. Interesting! I find it so hard not to give, in case the contralateral eye gets it, but no evidence for this @rheumnow #ACR22 Abstr#0459 https://t.co/yMcw2HGQUx https://t.co/tNKUgYNTdG

• The Use of Intravenous Methylprednisolone in Patients with Giant Cell Arteritis…

Morning stiffness has the highest correlate to disease activity in pregnant AS patients, as demonstrated in Abs 0374. I will indeed be focusing on this much more for my patients. #ACR22 #ACRbest @RheumNow https://t.co/9bmlQtGsLH https://t.co/qrxebQ6Ow1

• The BASDAI Index During Pregnancy - ACR Meeting Abstracts

RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its Faculty

Kunishita et al Abatacept in those with RA and prev cancer (or not). Equally effective. No significant difference in 5-year malignancy but those curves look like they are diverging to me! @rheumnow #ACR22 Abstr#0255 https://t.co/1E2SXMGbqD https://t.co/gTvOOnuzo0

• Is Abatacept as Effective and Safe in Rheumatoid Arthritis Patients with Previo…

What do you do if a person with #rheumatoidarthritis was great on 1st JAKi. It was 1st line advanced Rx @RheumNow #ACR22

They're #dopplegangers! #IgG4RD and #GPA both can have similar clinical manifestations, storiform fibrosis and elevated IgG4 levels. Distinguishing factors can be: necrosis, granulomatous inflammation, neutrophilic inflammation, and presence of ANCA #ACR22 @rheumnow https://t.co/6bHibsvcV8

DISCOVER-2: Guselkumab in bionaïve PsA Work productivity data at 2 yrs 64% employed at BL; 50% work impairment at BL 84% employed at BL continued to work Amongst unemployed at BL proportion of pts working rose by >=20% https://t.co/zqmfFvPPMi Abst #0509 #ACR22 @Rheumnow https://t.co/J9Fhj1qHfV

• Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activ…

Migratory oligoarticular arthritis of AAV favors the lower extremities and may herald a flare. – Dr. J Stone #ACR22 @rheumnow https://t.co/VdBaeNyCR3

Yamaguchi et al. Effect of concurrent RO62 abs in Jo1+ antisynthetase syndrome. Present in 16%. Associated more muscle involvement 85% vs 59% (p=0.011). Maybe more Raynauds 56% vs 38% (p=0.09) @rheumnow #ACR22 Abstr#0162 https://t.co/6XH6qNKkn7 https://t.co/1JQCtCWrw0

• Clinical Features Associated with the Presence of anti-SSA/Ro60 Antibodies in a…

"Serum complement levels are the Rosetta Stone for understanding lupus activity in pregnancy." Dr. Stone @RheumNow #ACR22 https://t.co/4FbThAZyvq

Raynaud's may not be first presenting symptom in SSc with RNA Pol3 antibodies. May be a mimic of early inflammatory arthritis. Implications for steroid use. @RheumNow #ACR22 #Pearls https://t.co/FO8dtOTn9V